NCT03152682

A Study Evaluating Good Idea on Glucose Homeostasis in a Healthy Population

A Multi-centre Randomized, Double-blind, Placebo-controlled, Crossover, Proof-of-concept Study to Evaluate the Efficacy and Safety of Good IdeaTM on Glucose Homeostasis in a Healthy Population

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: DoubleGood AB · Industry
• Sex: All
• Age: 18 Years – 50 Years
• Healthy volunteers: Accepted

Summary

A crossover design to evaluate the safety and efficacy of GoodIdea TM (trademark) on glucose homeostasis in a healthy population. Eligible participants will be given either the GoodIdea drink or placebo and a standardized meal and will consume both in approximately 15 minutes. Blood will be drawn at several time points over a 3 hour period to determine the study objectives. After a 7-day washout, the participants will come back to the clinic and and complete the visit consuming the opposite product given at the previous visit. The primary objective is to see the difference of the two-hour iAUC for intravenous blood glucose between the active product (GoodIdea) and the placebo following a standardized meal.

Conditions

• Healthy

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	GoodIdea	Active product. Amount: 355mL. Consumed at a clinic visit over 14 minutes.
OTHER	Placebo	Non-active placebo product. Amount: 355mL. Consumed at a clinic visit over 14 minutes.

Timeline

• Start date: 2017-04-22
• Primary completion: 2017-08-15
• Completion: 2017-08-15
• First posted: 2017-05-15
• Last updated: 2022-11-22

Locations

1 site across 1 country: Canada